United States News All stories

Ultragenyx Pharmaceutical (NASDAQ:RARE) Phase 3 trials of setrusumab (UX143) in osteogenesis imperfecta failed to meet their primary endpoints, prompting the company to plan significant expense reductions while it evaluates next steps for the program.

Genmab (NASDAQ:GMAB) said it will discontinue further clinical development of acasunlimab, as the company sharpens its focus on the most value-creating opportunities in its late-stage portfolio amid an increasingly competitive landscape.

Theriva Biologics (NYSE:TOVX) said it has received Scientific Advice from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) on the design of a proposed Phase 3 trial evaluating VCN-01 in combination with gemcitabine and nab-paclitaxel for first-line treatment of metastatic pancreatic ductal adenocarcinoma.

Johnson & Johnson (NYSE:JNJ) said it has completed its acquisition of Halda Therapeutics OpCo in an all-cash transaction valued at $3.05 billion, strengthening the company’s oncology pipeline with a novel targeted-therapy platform

Azenta (NASDAQ:AZTA) has signed a binding agreement to sell its B Medical Systems business to THELEMA S.À R.L. for $63 million, as the company moves to streamline operations and focus on its core capabilities.

Nvidia Corp. (NASDAQ:NVDA) has formally concluded its $5 billion purchase of Intel (NASDAQ:INTC) common stock, according to a regulatory filing released Monday.

Zevra Therapeutics (NASDAQ:ZVRA) announced Monday it has entered into an exclusive distribution agreement with Ireland-based Uniphar to broaden access to MIPLYFFA® (arimoclomol).

Unicycive Therapeutics (NASDAQ:UNCY) said it has resubmitted its 505(b)(2) New Drug Application to the U.S. Food and Drug Administration for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients receiving dialysis.

Gogo (NASDAQ:GOGO) said it has completed flight testing and validation of its next-generation 5G air-to-ground broadband network, clearing a key milestone ahead of commercial deployment early next year.

Bluejay Diagnostics (NASDAQ:BJDX) said it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 (IL-6) for its Symphony™ cartridge program, marking a development milestone for the diagnostic platform.

ECARX (NASDAQ:ECX) said it has entered into a share subscription agreement with Lotus Technology (NASDAQ:LOT) to invest $23 million through a private placement, deepening their strategic collaboration in automotive software and computing platforms.

DHT Holdings (NYSE:DHT) said it has entered into sale agreements for two very large crude carriers, DHT China and DHT Europe, for a combined consideration of $101.6 million, as the tanker owner continues to optimize its fleet and strengthen liquidity.

MOGU (NYSE:MOGU) said it has entered into a share transfer agreement to acquire a minority equity interest in a China-based artificial intelligence infrastructure technology company, marking a strategic move into the AI sector

Brand Engagement Network (NASDAQ:BNAI) said it has entered into a Vendor Services Project Agreement with a unit of a leading global advertising agency to develop a custom artificial-intelligence engagement method for a top-10 global pharmaceutical company’s prescription drug.

Energy Fuels (NASDAQ:UUUU) announced on Dec. 29, 2025, that its fiscal year 2025 uranium operations significantly outperformed previously disclosed guidance.

The Denver-based producer, which has aggressively ramped up its domestic mining operations over the past 24 months, confirmed its position as the largest uranium producer in the United States by exceeding production benchmarks at both its mining and milling facilities.

Datavault AI (NASDAQ:DVLT) announced Monday that its board of directors has approved a dividend distribution of the "Dream Bowl Meme Coin II" token, a move designed to commemorate its strategic partnership with NFL Alumni Health.

Woodside Energy (NYSE:WDS) has successfully produced its first batch of ammonia at the Beaumont New Ammonia (BNA) facility in southeast Texas, marking the start of operations for one of the largest clean-energy infrastructure projects on the U.S. Gulf Coast.

iHuman (NYSE: IH), a leading provider of tech-powered intellectual development products in China, announced third-quarter financial results on Monday that reflected the persistent headwinds facing the country's early childhood education sector. The company saw a broad contraction across its key financial metrics and user engagement levels compared to the previous year.

HUTCHMED (NASDAQ:HCM) announced Monday that the China National Medical Products Administration (NMPA) has accepted its New Drug Application for fanregratinib and granted it priority review status.

Bolt Projects Holdings (NASDAQ:BSLK) shares are in focus after the company raised its fiscal year 2026 revenue guidance to $11 million, up from a previous estimate of $9 million.

CEA Industries (NASDAQ:BNC), which recently rebranded its trading ticker to BNC to reflect its pivot into a digital asset treasury (DAT) model, has implemented a limited-duration stockholder rights plan to thwart a takeover bid.

Bitcoin’s mainstream rise and institutional adoption in 2025 have been accompanied by a surge in violent “wrench attacks” as criminals increasingly target individual crypto holders.

XRP is heading into 2026 with rising momentum as regulatory clarity, spot ETFs and growing corporate treasury adoption drive institutional demand and on-chain utility.

Silver prices swung violently over the weekend, surging to record highs before plunging sharply, as shifting rate cut expectations and industrial demand fuelled crypto-like volatility.